The Epistemic Authority Question
The question that organizes this chapter β βdo patients count as knowers?β β is both a philosophical question and a practical one. The evidence reviewed here supports a qualified answer: patients are knowers of their own experience, of community-level patterns invisible to individual clinicians, and of research priorities that institutional funding mechanisms fail to identify. They are not necessarily knowers of statistical methodology, biochemistry, or clinical trial design β but neither are biostatisticians necessarily knowers of what it feels like to have post-exertional malaise.
De Boerβs discourse analysis of the Dutch ME/CFS Health Council advisory process illuminates the structural dimension of this question Boer (2021). When the Dutch Health Council convened to produce advisory guidance on ME/CFS, patients were invited to participate β but the terms of participation were biomedicalized: patients were expected to contribute experiential knowledge that could be translated into biomedical terms by professional experts. Non-biomedical patient knowledge β about the social consequences of illness, about the experience of healthcare invalidation, about what it means to lose a career, relationships, and identity β was rendered inadmissible by the framework of participation itself. The analysis documents a paradox: patient participation that is structured to admit only biomedical knowledge excludes the forms of knowledge that patients are uniquely positioned to provide, and thereby reproduces the epistemic exclusion it was designed to address.
The Long COVID movement has demonstrated an alternative model. The Patient-Led Research Collaborative (PLRC) β a group of patients with research training who mobilized during the early pandemic β conducted survey research, published in top-tier journals including Nature Reviews Microbiology, and produced a comprehensive review of Long COVID mechanisms that has been cited as a landmark synthesis (Davis et al. 2023). The PLRC also published clinical trial design recommendations informed by patient experience of symptom heterogeneity and PEM β explicitly making the argument that patient knowledge should shape trial methodology, not just trial recruitment (Vogel et al. 2024). The PLRC model at its best represents a convergence: patients who are also researchers, generating knowledge that is both experientially grounded and methodologically rigorous.
The Ziegler 2022 citizen science study β in which Long COVID patients (including seven with ME/CFS on the patient advisory board) collaboratively developed a needs-based research agenda β demonstrates that patient-identified research priorities differ from institutionally-identified ones, and that the difference is informative rather than problematic (Ziegler et al. 2022). The fact that patients prioritize different questions does not mean one set of questions is βcorrectβ β it means that the full research agenda is the union of both sets, not the intersection.
Whether patients βcount as knowersβ is not a question that can be answered once and for all. It is a question that must be answered differently for different types of knowledge claims. Patients are authoritative about their own experience; patient communities are authoritative about community-level patterns; patient-researchers are authoritative about research that incorporates experiential and technical expertise. The epistemic challenge is not to determine whether patients count β it is to determine for what they count, and to design knowledge-production systems that admit the right kinds of patient knowledge at the right points in the research process. (Certainty: N/A β this is a synthesis of evidence and a normative argument, not a factual claim.)
Consequence: The question of epistemic authority determines whether the infrastructure this chapter describes β patient-funded research, patient-initiated biobanks, patient-developed PROMs, patient online communities β is treated as legitimate knowledge production or as an elaborate coping mechanism. The answer matters for research funding (are patient-identified priorities fundable?), for clinical guidelines (is patient-reported evidence admissible?), and for drug development (do patient-identified endpoints count?). The evidence reviewed here suggests that patient knowledge, when appropriately integrated with professional expertise, improves research quality β not as a concession to patient preference, but as a methodological principle. Severity applicability: the epistemic authority question is most urgent for patients whose knowledge is most likely to be dismissed β those with severe/very severe disease whose testimony is least likely to reach institutional ears, and those from marginalized groups whose credibility is doubly discounted.